BJ9-33527-43825
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 740 / OK
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-14
-
2021-03-21
Dose 2 — Pfizer-BioNTech
- 2021-03-21
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to workAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, DiarrheaAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
-
2021-04-04
Survey response — day 14, dose 2MedDRA: Autonomic nervous system imbalance, Dizziness, Fatigue, Feeling abnormal, Heart rate increased, Hypotension, Tremor — Feeling: Fair · Be unable to workFree text: Dysautonomia - Dizzy, fatigue, high pulse rate, low blood pressure, shaking, brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-17
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: Vasculitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: VasculitisMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-03
-
2022-10-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — day 14, dose 2
Symptoms: Dysautonomia - Dizzy, fatigue, high pulse rate, low blood pressure, shaking, brain fog
Release 12 — 12 months, dose 3
Symptoms: Vasculitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autonomic nervous system imbalance | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Hypotension | ✓ | ✓ | ✓ |
| SD | Tremor | ✓ | ✓ | ✓ |
| SD | Vasculitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release